Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

2.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shengxian decoction suppresses malignant progression of lung adenocarcinoma by enhancing CD8<sup>+</sup> T cell function via the FYN-PI3K/AKT axis.

Chinese medicine·2026
Same author

Genetically predicted lower FLT3L levels increase the risk of hypertrophic cardiomyopathy partly mediated by phosphate: Evidence from a 2-step Mendelian randomization analysis.

Medicine·2026
Same author

Translating Evidence into Obstetric Care: Developing a Best Practice-Informed Stepped-Care Clinical Algorithm for the Management of Gestational Insomnia.

Nature and science of sleep·2026
Same author

Retraction notice for "MicroRNA-133b-5p Is Involved in Cardioprotection of Morphine Preconditioning in Rat Cardiomyocytes by Targeting Fas" [Canadian Journal of Cardiology, Volume 32, Issue 8, August 2016, Pages 996-1007. doi:10.1016/j.cjca.2015.10.019].

The Canadian journal of cardiology·2026
Same author

Lymphocyte-Predominant Ascites as a Clue to Peritoneal Tuberculosis: Two Case Reports and a Literature Review.

Infection and drug resistance·2026
Same author

Circadian gatekeepers of the gut-brain-immune axis: implications for neuroinflammation and neurodegeneration.

Journal of neuroinflammation·2026

Related Experiment Video

Updated: Apr 21, 2026

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
10:46

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models

Published on: May 3, 2017

10.5K

Dexmedetomidine directly increases tau phosphorylation.

Chunxia Huang1, Yuen-Shan Ho2, Olivia Tsz-Wa Ng1

  • 1Department of Anaesthesiology, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China Laboratory of Neurodegenerative Diseases, Department of Anatomy, LKS Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.

Journal of Alzheimer'S Disease : JAD
|November 7, 2014
PubMed
Summary

Dexmedetomidine exposure increases tau phosphorylation in rat neurons and brains. While in vitro effects are short-lived and site-specific, in vivo impacts are more complex, warranting further study on long-term cognitive effects.

Keywords:
Anestheticsdexmedetomidinehypothermiaprotein kinasestau phosphorylation

More Related Videos

In Vivo Microdialysis Method to Collect Large Extracellular Proteins from Brain Interstitial Fluid with High-molecular Weight Cut-off Probes
08:17

In Vivo Microdialysis Method to Collect Large Extracellular Proteins from Brain Interstitial Fluid with High-molecular Weight Cut-off Probes

Published on: September 26, 2018

14.3K
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.0K

Related Experiment Videos

Last Updated: Apr 21, 2026

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
10:46

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models

Published on: May 3, 2017

10.5K
In Vivo Microdialysis Method to Collect Large Extracellular Proteins from Brain Interstitial Fluid with High-molecular Weight Cut-off Probes
08:17

In Vivo Microdialysis Method to Collect Large Extracellular Proteins from Brain Interstitial Fluid with High-molecular Weight Cut-off Probes

Published on: September 26, 2018

14.3K
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.0K

Area of Science:

  • Neuroscience
  • Anesthesiology
  • Biochemistry

Background:

  • Anesthetic agents are linked to abnormal tau protein phosphorylation, a precursor to neurofibrillary tangles.
  • Dexmedetomidine's specific effects on tau phosphorylation require detailed investigation.

Purpose of the Study:

  • To evaluate the direct (in vitro) and indirect (in vivo) effects of dexmedetomidine on tau phosphorylation.
  • To assess tau phosphorylation at specific sites (AT8, AT180, S396) in response to dexmedetomidine exposure.

Main Methods:

  • Primary cortical neuron cultures from Sprague-Dawley (SD) rat embryos were exposed to dexmedetomidine.
  • Adult male SD rats received intravenous dexmedetomidine, followed by western blot and immunohistochemical analysis of brain samples.
  • Tau phosphorylation was assessed using western blot analysis at specific epitopes.

Main Results:

  • In vitro studies showed significant hyperphosphorylation at the S396 site, diminishing by 6 hours.
  • In vivo studies under normothermic conditions revealed significant hyperphosphorylation at the AT8 site (cortex and hippocampus) and AT180 site (hippocampus).
  • Direct effects on neurons were epitope-specific and transient; in vivo effects were region-dependent and complex.

Conclusions:

  • Dexmedetomidine increases tau phosphorylation both in vitro and in vivo under normothermic conditions.
  • The direct impact of anesthetics on neurons is epitope-specific and short-lived.
  • Further research is needed to understand the long-term consequences of dexmedetomidine on tau pathology and cognitive function.